Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors with Activating Mutations in MAP2K1
Mónica Fumero-Velázquez, Michael Hagstrom, Soneet Dhillon, Tara Geraminejad, Shantel Olivares, Michele Donati, Daniel Nosek, Pia Waldenbäck, Dmitry Kazakov, Brandon S. Sheffield, Victor A. Tron, Pedram Gerami*
Dive into the research topics of 'Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors with Activating Mutations in MAP2K1'. Together they form a unique fingerprint.